PurMinds is a drug development and API supply company using psychopharmacological compounds for the treatment of neurological disorders.

Its NeuroLabs and production facility in Ontario has Health Canada-approved Controlled Substances licenses and can supply GMP-grade psychedelic compounds, including Psilocybin, MDMA, DMT, and LSD, for global clinical trials and treatments. Its drug pipeline focuses on innovative therapeutics that combine proven mechanisms of actions with discoveries in psychoplastogens and their ability to promote neuroplasticity and neuro-rejuvenation.

Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


33 in total